Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Tokano

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 28, 2001
[Central nervous system lesions]Y Tokano
Ryoikibetsu Shokogun Shirizu|March 1, 1994
[Progressive systemic sclerosis]Y Tokano, S Hirose
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 30, 1999
[Alpha 1-acid glycoprotein (alpha 1-AG)]Y Tokano, H Hashimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 1, 1990
[Interstitial lung disease in systemic lupus erythematosus, progressive systemic sclerosis and dermatomyositis]Y Tokano, H Hashimoto, S Hirose
Immunologic Research|January 1, 1994
Determination of IgG subclasses of immunoglobulin preparations for intravenous injection and the problems involvedY Tokano, Y Umezawa, K Okumura
Ryumachi. [Rheumatism]|December 1, 1988
[Expanded clinical and basic profile of rheumatoid factors. 2. Analysis of IgG in normal subjects and patients with rheumatoid arthritis using nuclear magnetic resonance]Y Tokano, H Hashimoto, Y Okumura, et al.
Internal Medicine (Tokyo, Japan)|May 4, 1999
The expression of LFA-1, ICAM-1, CD80 and CD86 molecules in lupus patients: implication for immunotherapyY Takasaki, K Abe, Y Tokano, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|February 1, 1997
[The relation between IgG subclasses and clinical manifestations in patients with active systemic lupus erythematosus]M Tsujimura, Y Tokano, Y Takasaki, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 17, 1998
[New therapeutic strategy for autoimmune diseases. 2) Abnormality in expression of cell surface molecules in systemic erythematodes and its therapeutic application]Y Takasaki, K Abe, Y Tokano, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|February 1, 1996
The expression of lymphocyte function associated antigen-1, intercellular adhesion molecule-1 on peripheral blood lymphocytes in patients with systemic lupus erythematosusH Kaneko, Y Tokano, H Hashimoto, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 28, 2001
[Central nervous system lesions]Y Tokano
Ryoikibetsu Shokogun Shirizu|March 1, 1994
[Progressive systemic sclerosis]Y Tokano, S Hirose
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 30, 1999
[Alpha 1-acid glycoprotein (alpha 1-AG)]Y Tokano, H Hashimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 1, 1990
[Interstitial lung disease in systemic lupus erythematosus, progressive systemic sclerosis and dermatomyositis]Y Tokano, H Hashimoto, S Hirose
Immunologic Research|January 1, 1994
Determination of IgG subclasses of immunoglobulin preparations for intravenous injection and the problems involvedY Tokano, Y Umezawa, K Okumura
Ryumachi. [Rheumatism]|December 1, 1988
[Expanded clinical and basic profile of rheumatoid factors. 2. Analysis of IgG in normal subjects and patients with rheumatoid arthritis using nuclear magnetic resonance]Y Tokano, H Hashimoto, Y Okumura, et al.
Internal Medicine (Tokyo, Japan)|May 4, 1999
The expression of LFA-1, ICAM-1, CD80 and CD86 molecules in lupus patients: implication for immunotherapyY Takasaki, K Abe, Y Tokano, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|February 1, 1997
[The relation between IgG subclasses and clinical manifestations in patients with active systemic lupus erythematosus]M Tsujimura, Y Tokano, Y Takasaki, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 17, 1998
[New therapeutic strategy for autoimmune diseases. 2) Abnormality in expression of cell surface molecules in systemic erythematodes and its therapeutic application]Y Takasaki, K Abe, Y Tokano, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|February 1, 1996
The expression of lymphocyte function associated antigen-1, intercellular adhesion molecule-1 on peripheral blood lymphocytes in patients with systemic lupus erythematosusH Kaneko, Y Tokano, H Hashimoto, et al.
Pageof 6